Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3766 USD | +2.34% | +2.39% | -43.30% |
Financials (USD)
Sales 2024 * | 700K | Sales 2025 * | 700K | Capitalization | 9.89M |
---|---|---|---|---|---|
Net income 2024 * | -15M | Net income 2025 * | -19M | EV / Sales 2024 * | 14.1 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 14.1 x |
P/E ratio 2024 * |
-0.88
x | P/E ratio 2025 * |
-0.75
x | Employees | 18 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 66.15% |
Latest transcript on BioCardia, Inc.
1 day | +2.34% | ||
1 week | +2.39% | ||
Current month | -7.47% | ||
1 month | -10.14% | ||
3 months | -25.05% | ||
6 months | -0.71% | ||
Current year | -43.30% |
Managers | Title | Age | Since |
---|---|---|---|
Peter Altman
CEO | Chief Executive Officer | 57 | 01-12-31 |
David McClung
DFI | Director of Finance/CFO | 61 | 13-08-31 |
Chief Tech/Sci/R&D Officer | - | 17-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Simon Stertzer
BRD | Director/Board Member | 88 | 01-12-31 |
Jay Moyes
BRD | Director/Board Member | 70 | 10-12-31 |
Richard Krasno
BRD | Director/Board Member | 82 | 16-10-23 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 0.368 | -3.03% | 68,172 |
24-04-24 | 0.3795 | +0.93% | 73,379 |
24-04-23 | 0.376 | +2.23% | 80,861 |
24-04-22 | 0.3678 | +2.17% | 66,915 |
24-04-19 | 0.36 | -4.51% | 97,291 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-43.30% | 9.89M | |
-2.31% | 103B | |
+0.56% | 95.71B | |
+1.69% | 22.02B | |
-17.37% | 20.9B | |
-9.30% | 17.85B | |
-41.01% | 16.21B | |
-14.85% | 15.52B | |
+3.21% | 13.86B | |
+33.54% | 12.04B |
- Stock Market
- Equities
- BCDA Stock